JVMRX
Price
$27.58
Change
+$0.01 (+0.04%)
Updated
Jun 5 closing price
Net Assets
21.46B
PCMVX
Price
$15.40
Change
-$0.01 (-0.06%)
Updated
Jun 5 closing price
Net Assets
2.42B
Interact to see
Advertisement

JVMRX vs PCMVX

Header iconJVMRX vs PCMVX Comparison
Open Charts JVMRX vs PCMVXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$27.58
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets21.46B
Principal MidCap Value I A
Price$15.40
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets2.42B
JVMRX vs PCMVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMRX vs. PCMVX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Buy and PCMVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 21.5B vs. PCMVX (2.42B). PCMVX pays higher dividends than JVMRX: PCMVX (1.08) vs JVMRX (0.91). JVMRX was incepted earlier than PCMVX: JVMRX (14 years) vs PCMVX (6 years). PCMVX (1.09) is less costly to investors than JVMRX (0.76). PCMVX is a more actively managed with annual turnover of: 55.30 vs. JVMRX (47.00). PCMVX has a lower initial minimum investment than JVMRX: PCMVX (1000) vs JVMRX (1000000). JVMRX annual gain was more profitable for investors over the last year : -3.44 vs. PCMVX (-9.80). JVMRX return over 5 years is better than : 40.08 vs. PCMVX (22.46).
JVMRXPCMVXJVMRX / PCMVX
Total Expense Ratio0.751.0770%
Annual Report Gross Expense Ratio0.761.0970%
Fund Existence14 years6 years-
Gain YTD2.339-0.581-403%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.5B2.42B888%
Annual Yield % from dividends0.911.0884%
Returns for 1 year-3.44-9.8035%
Returns for 3 years5.97-7.75-77%
Returns for 5 years40.0822.46178%
Returns for 10 years38.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDECX21.76N/A
N/A
Fidelity Advisor Capital Development C
PJHRX29.20N/A
N/A
PGIM Jennison Health Sciences R
IVITX22.44N/A
N/A
VY® Invesco Growth and Income S2
RBCRX9.80N/A
N/A
RBC China Equity R6
HESAX41.79N/A
N/A
Horizon Defensive Core Advisor